|Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report|
C Kearon, EA Akl, J Ornelas, A Blaivas, D Jimenez, H Bounameaux, ...
Chest 149 (2), 315-352, 2016
|Oral rivaroxaban for symptomatic venous thromboembolism|
New England Journal of Medicine 363 (26), 2499-2510, 2010
|Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer|
PS Wells, DR Anderson, M Rodger, JS Ginsberg, C Kearon, M Gent, ...
Thrombosis and haemostasis 83 (03), 416-420, 2000
|Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis|
PS Wells, DR Anderson, M Rodger, M Forgie, C Kearon, J Dreyer, ...
New England Journal of Medicine 349 (13), 1227-1235, 2003
|Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using …|
PS Wells, DR Anderson, M Rodger, I Stiell, JF Dreyer, D Barnes, M Forgie, ...
Annals of internal medicine 135 (2), 98-107, 2001
|Value of assessment of pretest probability of deep-vein thrombosis in clinical management|
PS Wells, DR Anderson, J Bormanis, F Guy, M Mitchell, L Gray, ...
The Lancet 350 (9094), 1795-1798, 1997
|A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism|
C Kearon, M Gent, J Hirsh, J Weitz, MJ Kovacs, DR Anderson, AG Turpie, ...
New England Journal of Medicine 340 (12), 901-907, 1999
|Systematic overview of warfarin and its drug and food interactions|
AM Holbrook, JA Pereira, R Labiris, H McDonald, JD Douketis, ...
Archives of internal medicine 165 (10), 1095-1106, 2005
|Use of a clinical model for safe management of patients with suspected pulmonary embolism|
PS Wells, JS Ginsberg, DR Anderson, C Kearon, M Gent, AG Turpie, ...
Annals of internal medicine 129 (12), 997-1005, 1998
|Accuracy of clinical assessment of deep-vein thrombosis|
PS Wells, J Hirsh, DR Anderson, AWA Lensing, G Foster, C Kearon, ...
The Lancet 345 (8961), 1326-1330, 1995
|Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism|
C Kearon, JS Ginsberg, MJ Kovacs, DR Anderson, P Wells, JA Julian, ...
New England Journal of Medicine 349 (7), 631-639, 2003
|Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis|
N Martel, J Lee, PS Wells
Blood 106 (8), 2710-2715, 2005
|Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines|
SM Bates, R Jaeschke, SM Stevens, S Goodacre, PS Wells, ...
Chest 141 (2), e351S-e418S, 2012
|Low-molecular-weight heparin in the treatment of patients with venous thromboembolism|
New England Journal of Medicine 337 (10), 657-662, 1997
|Interactions of warfarin with drugs and food|
PS Wells, AM Holbrook, NR Crowther, J Hirsh
Annals of internal medicine 121 (9), 676-683, 1994
|Rivaroxaban or aspirin for extended treatment of venous thromboembolism|
JI Weitz, AWA Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, ...
New England Journal of Medicine 376 (13), 1211-1222, 2017
|Computed tomographic pulmonary angiography vs ventilation-perfusion lung scanning in patients with suspected pulmonary embolism: a randomized controlled trial|
DR Anderson, SR Kahn, MA Rodger, MJ Kovacs, T Morris, A Hirsch, ...
Jama 298 (23), 2743-2753, 2007
|Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy|
MA Rodger, SR Kahn, PS Wells, DA Anderson, I Chagnon, G Le Gal, ...
Cmaj 179 (5), 417-426, 2008
|Apixaban to prevent venous thromboembolism in patients with cancer|
M Carrier, K Abou-Nassar, R Mallick, V Tagalakis, S Shivakumar, ...
New England Journal of Medicine 380 (8), 711-719, 2019
|Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies|
MH Prins, AWA Lensing, R Bauersachs, B Van Bellen, H Bounameaux, ...
Thrombosis journal 11 (1), 1-10, 2013